Clinical evaluation of moroctocog alfa (AF-CC), a new generation of B-domain deleted recombinant factor VIII (BDDrFVIII) for treatment of haemophilia A: demonstration of safety, efficacy, and pharmacokinetic equivalence to full-length recombinant factor VIII

✍ Scribed by M. RECHT; L. NEMES; M. MATYSIAK; M. MANCO-JOHNSON; J. LUSHER; M. SMITH; P. MANNUCCI; C. HAY; T. ABSHIRE; A. O’BRIEN; B. HAYWARD; C. UDATA; D.A. ROTH; S. ARKIN

• Book ID: 108775270
• Publisher: John Wiley and Sons
• Year: 2009
• Tongue: English
• Weight: 225 KB
• Volume: 15
• Category: Article
• ISSN: 1351-8216
• DOI: 10.1111/j.1365-2516.2009.02027.x